Endovascular Aneurysm Sealing: Early and Midterm Results From the EVAS FORWARD Global Registry

Conclusion: The EVAS FORWARD Global Registry documents the 12-month outcome of EVAS in an unselected group of patients with challenging aortic morphology. The results at present appear acceptable with regard to perioperative outcomes and complications. The type II endoleak rate is low. The place of EVAS in the armamentarium of techniques to treat AAAs will be defined by durability data in the longer term.

Source: Journal of Endovascular Therapy - September 12, 2016 Category: Surgery Authors: Thompson, M. M., Heyligers, J. M., Hayes, P. D., Reijnen, M. M. P. J., Böckler, D., Schelzig, H., de Vries, J.-P. P. M., Krievins, D., Holden, A., for the EVAS FORWARD Global Registry Investigators Tags: Endovascular Aneurysm Sealing Source Type: research